Exploring the Interaction of Indole-3-Acetonitrile with Neuroblastoma Cells: Understanding the Connection with the
Catarina Moura1,2,3, Ana Salomé Correia1,2,3, Nuno Vale1,2,4
1PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Plácido da Costa, 4200-450 Porto, Portugal.
Abstract:
Indole-3-acetonitrile, a compound produced by bacteria and plants as a defense and survival signal in response to attacks, has been recently discovered as a metabolite produced by human cancer cells. This discovery suggests a potential association between IAN and cancer progression in patients. Consequently, the aim of this work was to study the effects of IAN on a specific cancer cell line, SH-SY5Y, and elucidate its connection to the serotonin and dopamine pathways by examining the precursors of these neurotransmitters. To achieve this, a cellular viability assay was conducted, along with a morphological evaluation of the cells under both normal and stress conditions. Our results demonstrated that for the highest concentrations in our study, IAN was able to reduce the cellular viability of the cells. Furthermore, when IAN was combined with the amino acids that originate the neurotransmitters, it was possible to observe that in both combinations there was a decrease in the viability of the cells. Thus, IAN may in fact have some influence on both the serotonin and dopamine pathways since changes in cell viability were observed when it was added together with the amino acids. This preliminary study indicates the presence of an interaction between IAN and neuroblastoma cells that justifies further exploration and study.
Insights
Indole-3-acetonitrile (IAN), found in cancer cells, reduced neuroblastoma cell viability. IAN also impacted cell viability when combined with serotonin and dopamine precursors, suggesting a link to these neurotransmitter pathways.
Area of Science:
- Biochemistry
- Cancer Biology
- Neuroscience
Background:
- Indole-3-acetonitrile (IAN) is a plant and bacterial signaling molecule.
- IAN is a newly identified metabolite in human cancer cells.
- This suggests a potential role for IAN in cancer progression.
Purpose of the Study:
- To investigate the effects of IAN on SH-SY5Y neuroblastoma cells.
- To explore IAN's potential connection to serotonin and dopamine pathways.
- To examine IAN's influence on neurotransmitter precursor metabolism.
Main Methods:
- Cellular viability assays were performed on SH-SY5Y cells.
- Morphological evaluation of cells under normal and stress conditions.
- Assays included IAN alone and in combination with neurotransmitter amino acid precursors.
Main Results:
- High concentrations of IAN reduced SH-SY5Y cell viability.
- Combining IAN with serotonin and dopamine precursors also decreased cell viability.
- Observed viability changes suggest IAN influences these neurotransmitter pathways.
Conclusions:
- IAN interacts with neuroblastoma cells.
- IAN may affect serotonin and dopamine pathways.
- Further research is warranted to elucidate IAN's role in cancer.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists